- (Labs)
- (Mabloc)
3 Projects
Mabloc
Immunity for Humanity: A new era for combating infectious diseases.
About the lab
MABLOC is developing antibodies for the prevention and treatment of infectious diseases, especially those which may lead to potential new pandemics.
Antibodies are already widely used in medicine and they have proven effectiveness in the treatment of cancer, HIV, and other infectious diseases. MABLOC’s goal is to utilize these drugs to ameliorate suffering in parts of the world that are often neglected and to rapidly respond to new pandemic threats.
Members
David I. Watkins
Ph.D
Scientific CommittéeExperience
- President and Chief Scientific Officer - Mabloc
- Professor of Pathology – George Washington University School of Medical and Health Sciences.
- 1998 Elizabeth Glaser Scientist Award recipient.
- Fellow of American Academy of Microbiology.
- NIH Merit Award.
- Post-Doctoral Fellowship – Harvard Medical School, MA.
- Ph.D. – Immunology, University of Rochester, NY.
- M.Sc. – Immunology, University of Rochester, NY.
- B.Sc. – Botany & Zoology, University of Durham , UK.
Esper G.Kallás
M.D.Ph.DScientific CommittéeExperience
- Chief Medical Officer - Mabloc.
- Professor - Infectious and Parasitic Diseases, University of Sao Paulo, Brazil.
- Director - HIV Outpatient Clinic, University of Sao Paulo, Brazil.
- Director - Clinical Research Center, Hospital das Clínicas, University of Sao Paulo, Brazil.
- State of São Paulo Coronavirus Crises Committe member.
- COVID-19 Crisis Team Coordination member, Clinical Hospital, University of Sao Paulo, Brazil
- Visiting Professor - George Washington University School of Medical and Health Sciences.
Denis R. Burton
Ph.DScientific CommittéeExperience
- Scientific Director and Board Member - Mabloc.
- Chair - Immunology and Microbiology, The Scripps Research Institute, US.
- Immunologist - Massachusetts General Hospital, Harvard Medical School.
- Fellow of American Academy of Microbiology.
- Scientific Advisory Board Member - University of Lund, Sweden.
- Scientific Advisory Board Member - Krebs Institute, University of Sheffiled, UK.
- Science Committe Member - Global HIV Vaccine Initiative.
- Ph.D. - Physical Biochemistry, University of Lund, Sweden.
- First Class Honors - Oxford University
Vanderson Rocha
M.D.Ph.DScientific CommittéeExperience
- Doctor - Biotechnological Therapy, University of Paris 7, France.
- Professor - Hematology, Hemotherapy and Cell Therapy, Faculty of Medicine, University of São Paulo, Brazil.
- CEO - Pro-Blood Foundation.
- Consultant Professor - Oxford University, UK
Projects
Several locations will remain susceptible to yearly DENV and ZIKV outbreaks, while new regions across the globe will likely suffer epidemics similar to the one described in South.
%